AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Vaccine and immune globulin may protect breast-fed infants from hepatitis B.(Brief Article)
2002 JUL 4 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - When given the appropriate protection, infants of mothers who are chronic hepatitis B virus (HBV) carriers may be able to breast feed without becoming infected with HBV.
The researchers have conducted a prospective study of infants who were born of mothers deemed chronic hepatitis B virus (HBV) carriers (hepatitis B e antigen-positive), examining more than 300 infants who were given hepatitis B immune globulin as well as hepatitis B vaccine series after delivery. At least 101 of the 369 infants were breast-fed, said J.B. Hill and colleagues in the Department of Obstetrics and Gynecology at the Dallas, Texas university.
Only nine of the women, a third of whom breast fed their infants, exhibited signs of liver complications as evidenced by elevated levels of the liver enzyme alanine aminotransferase.
"Overall, there were nine cases of HBV infection transmission (2.4%)," reported Hill and coauthors.
After receiving all doses of the hepatitis B vaccine, each of the 101 breast-fed infants remained protected from HBV infection, based on serum testing for hepatitis B surface antigen (HBsAg). The babies were ...
- PEGASYS Approved for Chronic Hepatitis B in Switzerland.
- Newspaper article from: PR Newswire Europe December 22, 2004 700+ words
...Swissmedic, for the treatment of chronic hepatitis B. The approval has been granted...become a first-line treatment for chronic hepatitis B," he said, adding that PEGASYS...treatment of hepatitis C. About Chronic Hepatitis B Chronic hepatitis B is a major...
- PEGASYS(R) Approved in the European Union for the Treatment of Chronic...
- Press release article from: PR Newswire Europe February 25, 2005 700+ words
...Interferon Approved for the Treatment of Chronic Hepatitis B Roche announced today that the...2a (40KD)) for the treatment of chronic hepatitis B. The approval is granted for both...HBeAg-positive and HBeAg-negative chronic hepatitis B. PEGASYS offers the hope of a...
- PEGASYS(R) Receives Positive Opinion in the European Union for the Treatment of...
- Newspaper article from: PR Newswire Europe January 21, 2005 700+ words
...interferon to be indicated for treating chronic hepatitis B Roche announced today that the...2a (40KD)) for the treatment of chronic hepatitis B. The decision is granted for both...HBeAg-positive and HBeAg-negative chronic hepatitis B (CHB). The recommendation will...
- FDA Approves Pegasys(R) as the First and Only Pegylated Interferon for the...
- Press release article from: PR Newswire May 14, 2005 700+ words
...for 1.25 Million Americans with Chronic Hepatitis B NUTLEY, N.J., May 13 /PRNewswire...United States, for the treatment of chronic hepatitis B (CHB). Pegasys is the first...interferon approved for the treatment of chronic hepatitis B, including both variations of...
- New US Approval Makes PEGASYS the First and Only Pegylated Interferon indicated...
- Press release article from: PR Newswire Europe May 16, 2005 700+ words
...for 1.25 Million Americans With Chronic Hepatitis B Roche announced today that PEGASYS...Administration for the treatment of chronic hepatitis B (CHB). This makes PEGASYS...be approved for the treatment of chronic hepatitis B in the US. PEGASYS was approved...
- PEGASYS: Roche Files Chronic Hepatitis B Indication in the US, EU and...
- Press release article from: PR Newswire July 21, 2004 700+ words
...Switzerland for the treatment for chronic hepatitis B. If approved, PEGASYS will become...interferon indicated for the treatment of chronic hepatitis B, which is the 10th leading cause...HBeAg-positive and HBeAg-negative chronic hepatitis B, based on a solid clinical development...
- FDA Advisory Committee Unanimously Supports Approval of Gilead's Adefovir...
- Press release article from: Business Wire August 6, 2002 700+ words
...dipivoxil 10 mg, for the treatment of chronic hepatitis B. The committee's positive recommendation...in a broad range of patients with chronic hepatitis B. The FDA will consider the Advisory...nucleotide for use in the treatment of chronic hepatitis B and the first new treatment ...
- Gilead Submits New Drug Application to U.S. FDA for Adefovir Dipivoxil 10 mg...
- Press release article from: Business Wire March 21, 2002 700+ words
...for the treatment of patients with chronic hepatitis B, including treatment-naive and...antigen-negative patients and chronic hepatitis B patients with lamivudine-resistant...unmet medical needs of patients with chronic hepatitis B, Gilead has submitted a request...
Source: HighBeam Research, Vaccine and immune globulin may protect breast-fed infants from...